FOR 5170:  CytoLabs – Systematic Investigation and Exploitation of Cytochalasans

• Subject Area: Chemistry ; Biology ; Medicine
• Term: since 2021
• Website: Homepage
• Project identifier: Deutsche Forschungsgemeinschaft (DFG) - Project number 438841444

Cytochalasans are natural products produced by fungi which have many potent biological activities. They bind strongly to actin and thus significantly effect eukaryotic cells. They also display remarkable bioactivities in prokaryotes and as anti-viral compounds where actin cannot be the target. They inhibit protein synthesis, sugar transport, plant growth, tumor necrosis factor and angiogenesis and are involved in immunosuppression and virulence and avirulence of fungi towards plants and insects, although most molecular mechanisms underlying these processes are unknown. Cytochalasans are constructed from amino acids and polyketides and they are often oxidatively tailored. Many hundreds of family members are known, but very few systematic investigations of structure activity relationships have been reported because very few cytochalasans are commercially available. The proposed CytoLabs Research Unit aims to address these problems through a systematic and integrated collaborative project between groups with expertise in the discovery, chemical synthesis, bioengineering, cell biology, in vivo and in vitro biochemistry, in planta and ecological bioactivity of cytochalasans. It aims to be able to apply modern synthetic chemistry (Kalesse, Klahn) and synthetic biology (Cox) to rapidly create known and new cytochalasans. Specific chemical modifications will also be systematically incorporated to generate cytochalasans with new functionality (i.e. new molecular tools). These compounds will be systematically collected into a compound library and tested in vivo and in vitro (Stradal, Rottner, Stadler, Zeilinger) and used to probe their mechanisms of action. Meanwhile, discovery of new cytochalasans (and their biosynthetic genes) from fungi will also be important (Stadler), while studying plant responses to cytochalasan challenge (Franke, Hildebrandt) will open new avenues of ecological research. In parallel Beemelmanns will investigate the ecological role of cytochalasans in fungal/bacterial/insect communities. In addition the Stadler group runs a highly successful (and almost unique) scale-up platform for the bulk production and purification of natural products at up to 100 gram scale. Overall there will be eight high quality individual projects which are themselves leading-edge, but with a very high level of inter-project collaboration. Crucially, the creation of a curated compound library (Stadler), will be an underpinning technology platform which will enable effective collaboration and allow the RU to pursue multi-disciplinary long-term goals which are unachievable in single projects.

• DFG Programme: Research Units
• International Connection: Denmark, Sweden

Projects

• Coordination Funds (Applicant Cox, Russell J. )
• Cytolabs Project: Discovery and Broad Biological Characterization of New Cytochalasans and Curated Compound Library (Applicant Stadler, Marc )
• Engineering the Biosynthesis of Cytochalasans for the Development of New Molecular Tools (Applicant Cox, Russell J. )
• OMICs based analysis of cytochalasans in fungal-bacteria-insect interactions (Applicant Beemelmanns, Christine )
• Systematic Characterization of Cytochalasan Activities on Actin Dynamics in Mammalian Cells (Applicants Rottner, Klemens ;  Stradal, Theresia )
• Target - Oriented Screening of a Cytochalasan Compound Library (Applicant Zeilinger, Carsten )
• Total synthesis and semi synthetic derivatization of [13]cytochalasans (Applicant Klahn, Philipp )
• Total synthesis of 11-membered cytochalasins as new molecular tools (Applicant Kalesse, Markus )

• Spokesperson: Professor Dr. Russell J. Cox